Investors on the quest for market-beating returns often employ the strategy of stock picking. Making informed choices in stocks can greatly amplify your wealth.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
The closing price of NewAmsterdam Pharma Company NV (NASDAQ: NAMS) was $24.76 for the day, up 0.69% from the previous closing price of $24.59. In other words, the price has increased by $0.69 from its previous closing price. On the day, 0.63 million shares were traded. NAMS stock price reached its highest trading level at $24.835 during the session, while it also had its lowest trading level at $24.36.
Ratios:
Our analysis of NAMS’s different ratios will help us gain a deeper understanding of the company. For the most recent quarter (mrq), Quick Ratio is recorded 10.61 and its Current Ratio is at 10.61. In the meantime, Its Debt-to-Equity ratio is 0.00 whereas as Long-Term Debt/Eq ratio is at 0.00.
On March 14, 2024, Scotiabank started tracking the stock assigning a Sector Outperform rating and target price of $35.
On January 18, 2024, Guggenheim started tracking the stock assigning a Buy rating and target price of $30.Guggenheim initiated its Buy rating on January 18, 2024, with a $30 target price.
Insider Transactions:
Also, insider trades can serve as a great indicator of what management thinks about the future direction of a stock’s price. A recent insider transaction in this stock occurred on Oct 01 ’24 when Kooij Louise Frederika sold 45,000 shares for $15.72 per share. The transaction valued at 707,400 led to the insider holds 0 shares of the business.
Kooij Louise Frederika bought 45,000 shares of NAMS for $778,050 on Oct 01 ’24. On Sep 26 ’24, another insider, Audet Juliette Berangere, who serves as the Chief Business Officer of the company, bought 1,104 shares for $15.70 each. As a result, the insider paid 17,333 and bolstered with 1,104 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, NAMS now has a Market Capitalization of 2287474944 and an Enterprise Value of 1849545600. Its current Enterprise Value per Revenue stands at 55.056 whereas that against EBITDA is -10.049.
Stock Price History:
Over the past 52 weeks, NAMS has reached a high of $26.35, while it has fallen to a 52-week low of $8.64. The 50-Day Moving Average of the stock is 37.50%, while the 200-Day Moving Average is calculated to be 27.76%.
Shares Statistics:
NAMS traded an average of 328.47K shares per day over the past three months and 446870 shares per day over the past ten days. A total of 82.47M shares are outstanding, with a floating share count of 44.68M. Insiders hold about 51.64% of the company’s shares, while institutions hold 37.25% stake in the company. Shares short for NAMS as of 1728950400 were 548709 with a Short Ratio of 2.19, compared to 1726185600 on 422468. Therefore, it implies a Short% of Shares Outstanding of 548709 and a Short% of Float of 1.0299999.
